116 related articles for article (PubMed ID: 15652648)
1. Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth.
Herédi-Szabó K; Lubke J; Toth G; Murphy RF; Lovas S
Peptides; 2005 Mar; 26(3):419-22. PubMed ID: 15652648
[TBL] [Abstract][Full Text] [Related]
2. Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives.
Mezo G; Czajlik A; Manea M; Jakab A; Farkas V; Majer Z; Vass E; Bodor A; Kapuvári B; Boldizsár M; Vincze B; Csuka O; Kovács M; Przybylski M; Perczel A; Hudecz F
Peptides; 2007 Apr; 28(4):806-20. PubMed ID: 17254668
[TBL] [Abstract][Full Text] [Related]
3. Is lGnRH-III the most potent GnRH analog containing only natural amino acids that specifically inhibits the growth of human breast cancer cells?
Herédi-Szabó K; Murphy RF; Lovas S
J Pept Sci; 2006 Nov; 12(11):714-20. PubMed ID: 16967433
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies.
Pappa EV; Zompra AA; Diamantopoulou Z; Spyranti Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
Biopolymers; 2012; 98(6):525-34. PubMed ID: 23203758
[TBL] [Abstract][Full Text] [Related]
5. lGnRH-III -- a promising candidate for anticancer drug development.
Manea M; Mező G
Protein Pept Lett; 2013 Apr; 20(4):439-49. PubMed ID: 23016589
[TBL] [Abstract][Full Text] [Related]
6. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization and kinetic studies of an ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, Petromyzon marinus.
Silver MR; Sower SA
J Mol Endocrinol; 2006 Jun; 36(3):601-10. PubMed ID: 16720727
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of GnRH binding in the gonads and effects of lamprey GnRH-I and -III on reproduction in the adult sea lamprey.
Gazourian L; Deragon KL; Chase CF; Pati D; Habibi HR; Sower SA
Gen Comp Endocrinol; 1997 Nov; 108(2):327-39. PubMed ID: 9356228
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs.
Kovács M; Vincze B; Horváth JE; Seprodi J
Peptides; 2007 Apr; 28(4):821-9. PubMed ID: 17289216
[TBL] [Abstract][Full Text] [Related]
11. Patterns of proopiomelanotropin and proopiocortin gene expression and of immunohistochemistry for gonadotropin-releasing hormones (lGnRH-I and III) during the life cycle of a nonparasitic lamprey: relationship to this adult life history type.
Youson JH; Heinig JA; Khanam SF; Sower SA; Kawauchi H; Keeley FW
Gen Comp Endocrinol; 2006 Aug; 148(1):54-71. PubMed ID: 16364323
[TBL] [Abstract][Full Text] [Related]
12. Cloning and analysis of the lamprey GnRH-III cDNA from eight species of lamprey representing the three families of Petromyzoniformes.
Silver MR; Kawauchi H; Nozaki M; Sower SA
Gen Comp Endocrinol; 2004 Oct; 139(1):85-94. PubMed ID: 15474539
[TBL] [Abstract][Full Text] [Related]
13. Seasonal changes of brain GnRH-I, -II, and -III during the final reproductive period in adult male and female sea lamprey.
Sower SA; Balz E; Aquilina-Beck A; Kavanaugh SI
Gen Comp Endocrinol; 2011 Jan; 170(2):276-82. PubMed ID: 20709062
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis.
Khan MA; Prevost M; Waterston MM; Harvey MJ; Ferro VA
Vaccine; 2007 Mar; 25(11):2051-63. PubMed ID: 17240004
[TBL] [Abstract][Full Text] [Related]
15. Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
Manea M; Leurs U; Orbán E; Baranyai Z; Öhlschläger P; Marquardt A; Schulcz Á; Tejeda M; Kapuvári B; Tóvári J; Mezo G
Bioconjug Chem; 2011 Jul; 22(7):1320-9. PubMed ID: 21668011
[TBL] [Abstract][Full Text] [Related]
16. Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
Montagnani Marelli M; Manea M; Moretti RM; Marzagalli M; Limonta P
Int J Oncol; 2015 Jan; 46(1):243-53. PubMed ID: 25351635
[TBL] [Abstract][Full Text] [Related]
17. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
18. Immunization of pigs against chicken gonadotropin-releasing hormone-II and lamprey gonadotropin-releasing hormone-III: effects on gonadotropin secretion and testicular function.
Bowen A; Khan S; Berghman L; Kirby JD; Wettemann RP; Vizcarra JA
J Anim Sci; 2006 Nov; 84(11):2990-9. PubMed ID: 17032793
[TBL] [Abstract][Full Text] [Related]
19. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.
Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M
Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495
[TBL] [Abstract][Full Text] [Related]
20. Evidence that lamprey GnRH-III does not release FSH selectively in cattle.
Amstalden M; Zieba DA; Garcia MR; Stanko RL; Welsh TH; Hansel WH; Williams GL
Reproduction; 2004 Jan; 127(1):35-43. PubMed ID: 15056768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]